Answers are grounded in this paper and cite their sources.
Dermatomyositis is a rare inflammatory myopathy known for its unique skin symptoms and muscle inflammation leading to proximal muscle weakness. It can be classified as idiopathic, juvenile dermatomyositis, or amyopathic dermatomyositis in adults, and may be associated with solid organ tumors. The pathophysiology of the disease is most likely influenced by immune-related variables, but genetic and environmental factors may also play a significant role. The majority of patients who receive immunosuppressive medication treatment report success, but there are chances of relapse. We report a case of dermatomyositis relapse that is refractory to pulse therapy and methotrexate.
No takes yet. Share an insight, caveat, or question.
Athul et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: